首页> 外文期刊>The Journal of Biochemistry >Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders
【24h】

Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders

机译:机床学习算法在过氧化合物异甲型疾病鉴别诊断中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

We have established diagnostic thresholds of very long-chain fatty acids (VLCFA) for the differential diagnosis of peroxisomal disorders using the machine learning tools. The plasma samples of 131 controls and 90 cases were tested for VLCFA using gas chromatography-mass spectrometry following stable isotope dilution. These data were used to construct association rules and for recursive partitioning. The C26/22 in healthy controls ranged between 0.008 and 0.01. The C26 levels between 1.61 and 3.34 mu mol/l and C26/C22 between 0.05 and 0.10 are diagnostic of X-linked adrenoleukodystrophy (X-ALD). Very high levels of C26 ( 3.34 mu mol/l) and C26/C22 ratio ( 0.10) are diagnostic of Zellweger syndrome (ZS). Significant elevation of phytanic acid was observed in Refsum (t = 6.14, P 0.0001) and Rhizomelic chondrodysplasia punctata (RCDP) (t = 16.72, P 0.0001). The C26/C22 ratio is slightly elevated in RCDP (t = 2.58, P = 0.01) while no such elevation was observed in Refsum disease (t = 0.86, P = 0.39). The developed algorithm exhibited greater clinical utility (AUC: 0.99-1.00) in differentiating X-ALD, ZS and healthy controls. The algorithm has greater clinical utility in the differential diagnosis of peroxisomal disorders based on VLCFA pattern. Plasmalogens will add additional value in differentiating RCDP and Refsum disease.
机译:我们已经建立了使用机器学习工具的过氧血清疾病的差异诊断的非常长链脂肪酸(VLCFA)的诊断阈值。使用稳定的同位素稀释后,使用气相色谱 - 质谱法对VLCFA进行131个对照和90例的等离子体样品。这些数据用于构建关联规则和递归分区。健康对照中的C26 / 22范围为0.008和0.01。 1.61和3.34μmol/ l和C26 / c22之间的C26水平为0.05和0.10是X型肾上腺胁迫(X-ALD)的诊断。非常高水平的C26(&3.34μmmol/ l)和C26 / c22比(& 0.10)是Zellweger综合征(zs)的诊断。在Refsum(T = 6.14,P <0.0001)中观察到植物酸的显着升高(T = 6.14,P <0.0001)和根瘤菌软骨细胞增生斑点(RCDP)(T = 16.72,P&LT; 0.0001)。 C26 / C22比在RCDP(T = 2.58,P = 0.01)中略微升高,而在Refsum疾病中没有观察到这种升高(t = 0.86,p = 0.39)。开发算法在鉴别X-ALD,ZS和健康对照方面表现出更大的临床效用(AUC:0.99-1.00)。该算法基于VLCFA图案的过氧血清疾病差异诊断具有更大的临床效用。 Plasmalogens将增加额外的价值,用于区分RCDP和REFSUM疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号